Charing Cross Gestational Trophoblastic Disease Screening & Management Centre, Dept of Medical Oncology, Charing Cross Hospital Campus of Imperial College NHS Healthcare Trust, Fulham Palace Road, London, UK.
Future Oncol. 2010 Dec;6(12):1915-23. doi: 10.2217/fon.10.153.
Gestational trophoblastic disease is a spectrum of disorders ranging from premalignant hydatidiform moles through to malignant invasive moles, choriocarcinoma and rare placental site trophoblastic tumor. The latter are often collectively referred to as gestational trophoblastic tumors or neoplasia (GTN). Although most women can expect to be cured of their disease, many interesting questions arise in the management of gestational trophoblastic disease. Current issues pertain to diagnosis of GTN, predicting progression from hydatidiform moles to GTN and the emergence of drug resistance in GTN. Our understanding of the genetics of GTN has helped us answer some of these questions but many remain unresolved. This article seeks to address recent advances in the genetics of GTN in relation to diagnosis, etiology, prognosis and treatment.
妊娠滋养细胞疾病是一系列疾病,从良性葡萄胎到恶性侵袭性葡萄胎、绒毛膜癌和罕见的胎盘部位滋养细胞肿瘤。后者通常统称为妊娠滋养细胞肿瘤或肿瘤(GTN)。尽管大多数女性的疾病可以治愈,但在妊娠滋养细胞疾病的管理中出现了许多有趣的问题。目前的问题涉及 GTN 的诊断、预测葡萄胎向 GTN 的进展以及 GTN 中出现药物耐药性。我们对 GTN 遗传学的理解帮助我们回答了其中的一些问题,但仍有许多问题尚未解决。本文旨在探讨 GTN 遗传学在诊断、病因、预后和治疗方面的最新进展。